Rocket Lab's Neutron Delay: A Setback or a Buying Opportunity?
💡 Key Takeaway
Rocket Lab's Neutron delay is a prudent engineering decision that won't derail the company's path to profitability, making the sell-off a potential buying opportunity for long-term investors.
Rocket Lab Postpones Neutron Launch Again
Rocket Lab (RKLB) announced last week that it is delaying the inaugural launch of its Neutron reusable rocket, which was initially targeted for late 2026. The delay stems from a manufacturing issue with the carbon composite domes used in the rocket's first-stage propellant tanks. Air pockets were discovered between the carbon composite layers, which could weaken the domes' structural integrity. Although the issue might not have caused a catastrophic failure, Rocket Lab decided to err on the side of caution and develop a new manufacturing process to eliminate the air pockets.
The company now says it is targeting a launch in 2027, but CEO Peter Beck acknowledged that even this timeline is "ambitious," suggesting further delays are possible. The news triggered a 25% sell-off in Rocket Lab stock last week, reflecting investor disappointment over yet another setback for the highly anticipated Neutron rocket.
Rocket Lab had originally planned to launch Neutron in 2024, but the timeline has slipped multiple times due to technical challenges. The Neutron rocket is seen as a key growth driver for the company, as it will compete with SpaceX's Falcon 9 in the medium-lift launch market. However, the delay means Rocket Lab will have to rely on its smaller Electron rocket for longer.
Despite the delay, Rocket Lab emphasized that it is building the program's long-term infrastructure concurrently with the first rocket, which should enable faster scaling once the rocket is operational. The company also reiterated that it won't rush to the launch pad with unnecessary risk, prioritizing safety and reliability over speed.
What This Means for Me
Why the Neutron Delay Matters for RKLB Stock
The Neutron delay is significant because it pushes back Rocket Lab's entry into the medium-lift launch market, which is expected to be a major revenue driver. Neutron is designed to carry larger payloads and compete directly with SpaceX's Falcon 9, which currently dominates the commercial launch market. A delay means Rocket Lab will miss out on potential launch contracts and revenue in the near term.
However, the delay is not entirely unexpected. Rocket Lab had already pushed back the Neutron timeline multiple times, and the company has always emphasized a cautious approach to development. The fact that the issue was caught during manufacturing and addressed before launch is a positive sign of Rocket Lab's engineering rigor. Investors may be disappointed, but the delay does not necessarily indicate a fundamental problem with the rocket's design or the company's long-term prospects.
From a financial perspective, the delay is unlikely to have a material impact on Rocket Lab's near-term results. The company was only planning one Neutron launch in 2026, followed by three in 2027 and five in 2028. Even if the first launch slips to 2027, the revenue contribution from Neutron would have been minimal in the near term. Meanwhile, Rocket Lab's core Electron rocket business continues to perform well, and the company is expected to achieve profitability next year regardless of Neutron's timing.
Longer term, the delay could affect Rocket Lab's competitive position if it allows competitors to gain ground. However, the medium-lift market is large and growing, and Rocket Lab's focus on reusability and cost-efficiency could still make Neutron a compelling option once it is operational. The key risk is that further delays could erode investor confidence and make it harder for Rocket Lab to secure launch contracts.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| RKLB | Positive | The delay is a prudent move that prioritizes safety and long-term reliability. The sell-off presents a buying opportunity for long-term investors, as the company's path to profitability remains intact. |
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Buy the dip in RKLB; the Neutron delay is a minor setback in a long-term growth story.
Rocket Lab's cautious approach to Neutron development is sensible and should lead to a more reliable rocket. The delay does not affect the company's near-term financials, and Rocket Lab is still on track to achieve profitability next year. The stock's 25% drop is an overreaction, offering an attractive entry point for investors with a long-term horizon.
What This Means for Me

Read More
Rocket Lab's Iridium Deal Gets a Boost from Strong Earnings
Neutral Iridium's Q3 earnings beat strengthens the case for Rocket Lab's $8 billion acquisition, potentially making RKLB profitable and cash-flow positive by 2027, but the stock's high valuation leaves little room for error.
IRDMRKLBOct 24, 2026SPCX Stock Jumps 7.8% on Q3 Earnings: Is It a Buy?
Bullish SpaceX's Q3 earnings beat, driven by explosive AI revenue growth, justifies a bullish stance for risk-tolerant investors, but the extreme valuation and Musk's history of overpromising warrant caution.
SPCXRKLBASTSTSLAOct 21, 2026Rocket Lab's Neutron Delay: What It Means for RKLB
Neutral The Neutron delay to 2027 is a significant setback that pushes back revenue growth, but Rocket Lab's strong backlog and small launch dominance provide a cushion.
RKLBOct 20, 2026

